Folate supplementation in the dialysis patient - fragmentary evidence and tentative recommendations

被引：10

作者：

Westhuyzen, J ^{[1
]}

机构：

[1] Royal Brisbane Hosp, Div Chem Pathol, Conjoint Renal Lab, Brisbane, Qld 4029, Australia

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 11期

关键词：

D O I：

10.1093/ndt/13.11.2748

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2748 / 2750

页数：3

共 22 条

[1]

ANDERSEN KEH, 1977, CLIN NEPHROL, V8, P510

[2]

ARNADOTTIR M, 1993, CLIN NEPHROL, V40, P236

[3]

BERGWANGER CS, 1995, BRIT J SURG, V82, P726

[4] Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients [J].

Bostom, AG ;

Shemin, D ;

Lapane, KL ;

Nadeau, MR ;

Sutherland, P ;

Chan, J ;

Rozen, R ;

Yoburn, D ;

Jacques, PF ;

Selhub, J ;

Rosenberg, IH .

ATHEROSCLEROSIS, 1996, 123 (1-2) :193-202

[5] High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients [J].

Bostom, AG ;

Shemin, D ;

Lapane, KL ;

Hume, AL ;

Yoburn, D ;

Nadeau, MR ;

Bendich, A ;

Selhub, J ;

Rosenberg, IH .

KIDNEY INTERNATIONAL, 1996, 49 (01) :147-152

[6] FOLIC-ACID SAFETY AND TOXICITY - A BRIEF REVIEW [J].

BUTTERWORTH, CE ;

TAMURA, T .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 50 (02) :353-358

[7]

CHANARIN I, 1990, MEGALOBLASTIC ANAEMI, P77

[8]

CHAUVEAU P, 1993, KIDNEY INT, V43, pS72

[9]

Chauveau P, 1996, MINER ELECTROL METAB, V22, P106

[10] DO PATIENTS RECEIVING HEMODIALYSIS NEED FOLIC-ACID SUPPLEMENTS [J].

CUNNINGHAM, J ;

SHARMAN, VL ;

GOODWIN, FJ ;

MARSH, FP .

BRITISH MEDICAL JOURNAL, 1981, 282 (6276) :1582-1582

← 1 2 3 →